|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
Bristol-Myers Squibb Company 8-K 2009
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported): December 17, 2009
BRISTOL-MYERS SQUIBB COMPANY (Exact Name of Registrant as Specified in its Charter)
345 Park Avenue New York, NY, 10154 (Address of Principal Executive Office) Registrants telephone number, including area code: (212) 546-4000 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
(a) On December 17, 2009, the Board of Directors amended the Bylaws of the Registrant primarily to (i) reflect recent statutory developments regarding the setting of record dates and (ii) permit the Secretary and Treasurer of the Registrant to appoint Assistant Secretaries and Assistant Treasurers, respectively. The amendments are described below:
A copy of the revised Bylaws, effective December 17, 2009, is attached to this report as Exhibit 3.1.
(d) Exhibits.
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EXHIBIT INDEX
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||